Clinical trial
A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver
NCT00582400 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver
- Lead sponsor
- The University of Texas Medical Branch, Galveston
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2004
- Completion date
- April 30, 2010
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.